News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Thomas, McNerney & Partners II, LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/21/2022 |
4
| THOMAS MCNERNEY & PARTNERS LP (10% Owner) has filed a Form 4 on CLARUS THERAPEUTICS INC|
Txns:
| Sold 1,663,126 shares
@ $2.53, valued at
$4.2M
Sold 2,061,685 shares
@ $2.53, valued at
$5.2M
Sold 5,722 shares
@ $2.53, valued at
$14.5k
Sold 13,630 shares
@ $2.53, valued at
$34.5k
Sold 1,164 shares
@ $2.53, valued at
$2.9k
Sold 7,585 shares
@ $2.53, valued at
$19.2k
|
|
| 04/22/2019 |
4
| Thomas, McNerney & Partners II L.P. (10% Owner) has filed a Form 4 on CAS MEDICAL SYSTEMS INC|
Txns:
| Converted 6,802,834 shares
@ $2.389, valued at
$16.3M
Converted 24,125 shares
@ $2.389, valued at
$57.6k
Converted 71,075 shares
@ $2.389, valued at
$169.8k
Converted 3,906,315 shares
@ $2.389, valued at
$9.3M
Converted 13,881 shares
@ $2.389, valued at
$33.2k
Converted 40,772 shares
@ $2.389, valued at
$97.4k
Disposed/sold 12,300,186 shares
@ $2.45, valued at
$30.1M
Disposed/sold 43,944 shares
@ $2.45, valued at
$107.7k
Disposed/sold 119,872 shares
@ $2.45, valued at
$293.7k
Converted 94,182 convertible preferred
@ $0
Converted 334 convertible preferred
@ $0 |
|
| 02/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/06/2016 |
4
| Thomas, McNerney & Partners II L.P. (10% Owner) has filed a Form 4 on Invitae Corp |
| 05/07/2015 |
4
| Thomas, McNerney & Partners II, LLC (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 4,835,731 shares
@ $0 |
|
| 02/18/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/13/2015 |
4
| Thomas, McNerney & Partners II L.P. (10% Owner) has filed a Form 4 on CAS MEDICAL SYSTEMS INC|
Txns:
| Bought 1,591,037 shares
@ $1.3, valued at
$2.1M
Bought 8,025 shares
@ $1.3, valued at
$10.4k
Bought 5,938 shares
@ $1.3, valued at
$7.7k
|
|
| 01/30/2015 |
4
| Thomas, McNerney & Partners II, LLC (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Sold 730,000 shares
@ $53.11, valued at
$38.8M
|
|
| 01/12/2015 |
4
| Thomas, McNerney & Partners II, LLC (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 24,008 shares
@ $51.574, valued at
$1.2M
Exercised 59,277 warrants
@ $3.879, valued at
$229.9k
Exercised 169,630 warrants
@ $3.879, valued at
$658k
Exercised 90,228 warrants
@ $3.879, valued at
$350k
|
|
| 10/14/2014 |
4
| Thomas, McNerney & Partners II, LLC (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc. |
| 10/01/2014 |
4
| Thomas, McNerney & Partners II, LLC (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 12,226 shares
@ $20.598, valued at
$251.8k
Disposed/sold 46 shares
@ $20.598, valued at
$947.5
Exercised 64,918 warrants
@ $3.879, valued at
$251.8k
Exercised 243 warrants
@ $3.879, valued at
$942.6 |
|
| 10/01/2014 |
4
| Thomas, McNerney & Partners II, LLC (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.|
Txns:
| Converted 5,031,092 shares
@ $0
Bought 82,475 shares
@ $12, valued at
$989.7k
Converted 2,266,186 convertible preferred
@ $0
Converted 7,474,419 convertible preferred
@ $0
Converted 11,792,529 convertible preferred
@ $0
Converted 1,106,779 convertible preferred
@ $0
Converted 293,230 options to buy
@ $0.862, valued at
$252.8k
Converted 65,161 warrants
@ $3.879, valued at
$252.8k
Converted 267,899 options to buy
@ $0.862, valued at
$230.9k
Converted 59,532 warrants
@ $3.879, valued at
$230.9k
Converted 264,003 options to buy
@ $0.862, valued at
$227.6k
|
|
| 11/30/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/29/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|